Sofinnova Investments, Inc. Halozyme Therapeutics, Inc. Transaction History

Sofinnova Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$13.9 - $21.83 $1.01 Million - $1.58 Million	-72,481 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$14.93 - $19.53 $8.42 Million - $11 Million	-563,686 Reduced 88.61%	72,481 $1.29 Million
Q3 2019 Nov 14, 2019	SELL	$15.2 - $17.69 $821,286 - $955,826	-54,032 Reduced 7.83%	636,167 $9.87 Million
Q2 2019 Aug 13, 2019	BUY	$14.75 - $17.26 $4.26 Million - $4.99 Million	288,870 Added 71.98%	690,199 $11.9 Million
Q1 2019 May 15, 2019	BUY	$13.94 - $17.58 $5.59 Million - $7.06 Million	401,329 New	401,329 $6.46 Million

544

126M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.77B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.